Pricing Log in Create free account
Saturday 17 October 2026 Export MD’s income statement to Excel — free account

Pediatrix Medical Group, Inc.

MD Healthcare Medical Care Facilities

Pediatrix Medical Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 4.92% from fiscal 2024. In the quarter to June 2026, revenue grew 4.04%, EPS grew 6.52%, free cash flow fell 6.56% and total debt fell 3.84%, each against the same quarter a year earlier.

27.38 0.38 −1.37%
Market cap
$2.3B
P/E
13.1×
Fwd P/E
11.3×
Dividend yield
—
F-score
7/9
Altman Z
2.05
Beneish M
−2.86
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 1.83
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell 2 1 — — — — 1 — — — — —
Insider Ownership 0.00%

Capital & Financial Ratios $m

Market Cap 2,260.00
Revenue 1,950.63
Net Income 174.81
Free Cash Flow 228.61
Net Debt 180.05
Current Ratio 1.32
Debt/Equity 0.66
P/E ratio 13.10
Fwd P/E 11.30
P/S ratio 1.12
P/B ratio 2.47
Past 5Y EPS Growth —
This Y EPS Growth 15.09% (at or above 15%: strong)
Next Y EPS Growth 3.99%
Next Y revenue growth 2.46%
Next 5Y EPS Growth 7.11%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 1.2×, against a ten-year median of 1.5×; over the ten years it ranged from 0.6× in 2024 to 3.9× in 2019.
P/E against its own 10 years 42.13%
10-year low 10-year high
P/S against its own 10 years 53.96%
10-year low 10-year high
P/B against its own 10 years 85.29%
10-year low 10-year high
EV/Sales against its own 10 years 39.92%
10-year low 10-year high
EV/FCF against its own 10 years 24.25%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2024 Powerpack
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
2017 Powerpack
special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 178 349 500 404
Receivables 280 273 242 239
Inventory — — — —
Other 12 5 9 7
483 640 764 660
2023 2024 2025 Q'26
Payables 351 399 420 302
ST’ Debt 15 21 27 186
Other — — — —
389 434 459 502

Compound Annual Growth %

10y 5y 3y
Sales (3.66%) 1.99% (0.99%)
Cash Flow (3.03%) 5.79% 17.54%
Earnings (6.85%) 0.00% 35.60%
Book Value (9.83%) 2.98% (0.97%)

Revenue $m

Mar Jun Sep Dec Year
’26 476 488 — — —
’25 458 469 493 494 1,914
’24 495 504 511 502 2,013
’23 491 501 507 496 1,995
’22 482 486 490 514 1,972
’21 447 473 493 499 1,911
’20 441 415 461 417 1,734
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (130) 125 — — —
’25 (117) 137 137 114 271
’24 (125) 107 92 133 207
’23 (101) 89 80 69 137
’22 (97) 82 83 99 167
’21 (82) 54 61 44 77
’20 (142) 188 170 (12) 205
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (136) 124 — — —
’25 (121) 133 132 109 253
’24 (131) 100 86 130 185
’23 (108) 81 71 60 104
’22 (105) 76 76 90 137
’21 (91) 69 51 41 69
’20 (152) 181 165 (19) 176
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 0.36 0.49 — — —
’25 0.24 0.46 0.84 0.40 1.94
’24 0.05 (1.84) 0.23 0.36 (1.19)
’23 0.17 0.34 0.26 (1.50) (0.73)
’22 (0.25) 0.32 0.37 0.36 0.79
’21 0.21 0.41 0.36 0.55 1.53
’20 (0.23) (8.03) (0.49) (0.76) (9.55)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2.7
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 59.36 40.56 31.68 19.93 7.37 20.27 14.40 8.18 6.62 11.84

Analyst estimates 2026–2028

Powerpack
High 76.96 72.13 63.04 38.89 27.90 35.67 28.02 17.30 16.41 24.99
People
People Employees 7,400 7,675 7,625 5,165 5,600 5,000 5,250 5,170 4,305 4,315
Revenue/emp, $m 0.43 0.42 0.23 0.34 0.31 0.38 0.38 0.39 0.47 0.44
Income, $m
Income, $m Revenue 3,183 3,253 1,723 1,780 1,734 1,911 1,972 1,995 2,013 1,914
Gross margin, % 32.47 28.27 29.31 28.27 25.91 26.85 23.68 21.13 22.57 25.80
EBT 514 386 166 59 7 135 81 (48) (101) 216
EBT margin, % 16.14 11.85 9.65 3.30 0.41 7.08 4.13 (2.42) (5.03) 11.31
Net income 325 320 269 (1,498) (796) 131 66 (60) (99) 165
Depreciation 94 84 29 32 36 36 37 37 33 23
Per share, $
Per share, $ Revenue 34.44 35.20 18.91 21.32 20.79 22.53 23.63 24.27 24.16 22.76
Earnings 3.49 3.45 2.93 (17.94) (9.55) 1.53 0.79 (0.73) (1.19) 1.94
Cash flow 4.80 5.53 3.44 4.28 2.45 0.90 2.00 1.67 2.48 3.22
Capex (0.42) (0.28) (0.19) (0.23) (0.35) (0.09) (0.36) (0.41) (0.26) (0.22)
Free cash flow 4.38 5.25 3.26 4.05 2.11 0.82 1.64 1.27 2.21 3.00
Book value 29.87 33.18 33.89 17.95 8.97 10.57 10.68 10.33 9.18 10.30
Shares, m 92 92 91 83 83 85 83 82 83 84
Valuation, ×
Valuation, × P/E 19.13 15.87 11.26 0.00 0.00 17.78 18.78 0.00 0.00 11.03
P/S 1.94 1.56 1.74 1.00 1.20 1.21 0.64 0.39 0.54 0.94
P/B 2.24 1.65 0.97 1.54 2.79 2.57 1.41 0.91 1.43 2.08
EV/Sales 2.46 2.10 2.85 1.67 1.50 1.48 0.91 0.62 0.68 0.99
EV/FCF 19.35 14.10 16.57 11.48 14.81 40.83 13.13 11.79 7.38 7.51
Cash, $m
Cash, $m Operating cash flow 444 511 314 358 205 77 167 137 207 271
Capex (39) (26) (17) (19) (29) (8) (30) (33) (22) (18)
Free cash flow 405 485 297 338 176 69 137 104 185 253
Balance, $m
Balance, $m Working capital 138 96 157 190 1,105 413 1 95 205 305
Total debt 1,706 1,853 1,975 1,748 1,745 1,005 651 633 618 597
Net debt 1,639 1,782 1,907 1,566 516 518 548 456 269 98
Shareholders’ equity 2,761 3,066 3,088 1,499 748 897 892 849 765 866
Returns, %
Returns, % ROA 6.57 5.72 4.55 (29.71) (21.26) 4.31 2.62 (2.65) (4.53) 7.52
ROIC 8.12 5.86 3.11 3.50 4.85 8.97 7.50 0.35 (4.15) 13.55
ROE 12.50 11.00 8.73 (65.30) (70.90) 15.93 7.42 (6.94) (12.28) 20.28
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Pediatrix Medical Group, Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
ACHC Acadia Healthcare Company, Inc. $2.9B — (loss-making) 21.1× −0.39% (below 0%: shrinking) −63.64% (below 0%: shrinking) +856.54% (above 0%: growing) 100.00% 10.14% Compare
AVAH Aveanna Healthcare Holdings Inc. $2.8B 9.5× 10.4× +13.73% (above 0%: growing) +46.15% (above 0%: growing) +57.89% (above 0%: growing) 32.59% 11.93% Compare
GRDN Guardian Pharmacy Services, Inc. $2.5B 37.5× 39.5× +2.16% (above 0%: growing) +133.33% (above 0%: growing) +60.83% (above 0%: growing) 22.75% 5.87% Compare
BKD Brookdale Senior Living Inc. $2.4B — (loss-making) — (loss-making) −11.61% (below 0%: shrinking) n/m +533.14% (above 0%: growing) 29.94% 11.86% Compare
MD Pediatrix Medical Group, Inc. $2.3B 13.1× 11.3× +4.04% (above 0%: growing) +6.52% (above 0%: growing) −6.56% (below 0%: shrinking) 27.16% 11.67%
ADUS Addus HomeCare Corporation $2.2B 20.4× 14.9× +8.01% (above 0%: growing) +24.17% (above 0%: growing) +81.74% (above 0%: growing) 32.21% 10.32% Compare
SGRY Surgery Partners, Inc. $1.9B — (loss-making) — (loss-making) +2.75% (above 0%: growing) n/m −60.63% (below 0%: shrinking) 22.41% 12.78% Compare
ASTH Astrana Health, Inc. $1.9B 44.3× 29.7× +48.52% (above 0%: growing) +110.53% (above 0%: growing) −67.74% (below 0%: shrinking) 10.70% 3.53% Compare
ARDT Ardent Health, Inc. $1.7B 21.7× 7.7× −1.40% (below 0%: shrinking) −76.92% (below 0%: shrinking) +121.70% (above 0%: growing) 100.00% 3.44% Compare
Median of peers $2.3B 21.7× 18.0× +2.46% +35.16% +71.29% 31.07% 10.23%

All 55 Medical Care Facilities stocks →

Pediatrix Medical Group, Inc. (MD) key facts

  • Concern: Pediatrix Medical Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 4.92% from fiscal 2024.
  • Pediatrix Medical Group, Inc. (MD) is a Medical Care Facilities company in the Healthcare sector, listed on the New York Stock Exchange.
  • Net income was $165.4 million, or $1.94 per share (basic), a net margin of 8.64%.
  • As of October 16, 2026, MD traded at $27.38, a market capitalization of $2.3 billion.
  • At that price the stock trades at 13.1× trailing-twelve-month earnings and 1.1× sales; its P/E is higher than 42% of its own readings over the past ten years.
  • Return on equity was 20.3% and debt-to-equity 0.66.
  • Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 2.05 (grey zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Pediatrix Medical Group, Inc. (MD) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/MD · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com